Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PTC Therapeutics
(NASDAQ:PTCT)
Intraday
$25.13
-0.03
[-0.12%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$25.13
-0.03
[-0.12%]
Last update: 9:30AM
Get Real Time Here
Get Report
Watch
Q1 2024 Earnings in 7 days from now on Thu Apr 25th, after the market close
Conference call scheduled in 7 days at 16:30 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for PTC Therapeutics Stock (NASDAQ:PTCT)
PTC Therapeutics Stock (NASDAQ: PTCT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, April 12, 2024
Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $45 Price Target
Benzinga Newsdesk
-
6 days ago
Thursday, March 28, 2024
PTC Therapeutics Submits Sepiapterin MAA For Treatment Of PKU To EMA
Benzinga Newsdesk
-
Mar 28, 2024, 8:34AM
Friday, March 08, 2024
RBC Capital Reiterates Sector Perform on PTC Therapeutics, Maintains $28 Price Target
Benzinga Newsdesk
-
Mar 8, 2024, 11:35AM
Friday, March 01, 2024
PTC Therapeutics shares are trading higher after the company reported Q4 financial results.
Benzinga Newsdesk
-
Mar 1, 2024, 12:35PM
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Mar 1, 2024, 11:18AM
RBC Capital Maintains Sector Perform on PTC Therapeutics, Raises Price Target to $28
Benzinga Newsdesk
-
Mar 1, 2024, 10:29AM
Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $45 Price Target
Benzinga Newsdesk
-
Mar 1, 2024, 9:40AM
TD Cowen Maintains Market Perform on PTC Therapeutics, Lowers Price Target to $30
Benzinga Newsdesk
-
Mar 1, 2024, 8:44AM
Thursday, February 29, 2024
PTC Therapeutics Sees FY24 Revenue $600M-$680M Est. Vs $612.290M Est.
Benzinga Newsdesk
-
Feb 29, 2024, 4:40PM
Recap: PTC Therapeutics Q4 Earnings
Benzinga Insights
-
Feb 29, 2024, 4:25PM
PTC Therapeutics Q4 2023 Adj EPS $(0.240) Misses $0.500 Estimate, Sales $307.056M Miss $321.294M Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 4:24PM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Earnings Preview: PTC Therapeutics
Benzinga Insights
-
Feb 28, 2024, 1:01PM
Friday, January 26, 2024
Cantor Fitzgerald Maintains Overweight on PTC Therapeutics, Lowers Price Target to $45
Benzinga Newsdesk
-
Jan 26, 2024, 12:42PM
RBC Capital Maintains Sector Perform on PTC Therapeutics, Lowers Price Target to $22
Benzinga Newsdesk
-
Jan 26, 2024, 10:29AM
PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe
Vandana Singh
-
Jan 26, 2024, 9:00AM
PTC Therapeutics shares are trading lower after the company announced the CHMP of the EMA issued a negative opinion following the re-examination procedure for the conditional marketing authorization of Translarna.
Benzinga Newsdesk
-
Jan 26, 2024, 8:39AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jan 26, 2024, 8:05AM
Thursday, January 25, 2024
PTC Therapeutics shares are trading lower after the company announced the CHMP of the EMA issued a negative opinion following the re-examination procedure for the conditional marketing authorization of Translarna.
Benzinga Newsdesk
-
Jan 25, 2024, 4:43PM
CHMP Issues Negative Opinion For Renewal Of Conditional Marketing Authorization For Translarna Following Re-Examination Procedure; Per European Regulations, The European Commission Has 67 Days To Adopt The Opinion
Benzinga Newsdesk
-
Jan 25, 2024, 4:36PM
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Jan 25, 2024, 4:31PM
Monday, January 08, 2024
PTC Therapeutics Sees FY24 Revenue $600M-$850M Vs $652.89M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 9:31AM
PTC Therapeutics Sees FY23 Revenue ~$946M Vs $936.85M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 9:30AM
Tuesday, December 19, 2023
Morgan Stanley Downgrades PTC Therapeutics to Underweight, Announces $28 Price Target
Benzinga Newsdesk
-
Dec 19, 2023, 9:40AM
Monday, December 18, 2023
Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $51 Price Target
Benzinga Newsdesk
-
Dec 18, 2023, 9:46AM
Tuesday, December 05, 2023
PTC Therapeutics Updates On Translarna (Ataluren) Regulatory Activities In Europe And US; Says FDA suggested Request For Follow-Up Meeting To Align On Specific Contents That Could Support Potential NDA Filing
Benzinga Newsdesk
-
Dec 5, 2023, 4:19PM
Monday, November 20, 2023
Analyst Expectations for PTC Therapeutics's Future
Benzinga Insights
-
Nov 20, 2023, 10:00AM
Cantor Fitzgerald Reiterates Overweight on PTC Therapeutics, Maintains $51 Price Target
Benzinga Newsdesk
-
Nov 20, 2023, 9:28AM
Friday, October 27, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Oct 27, 2023, 1:30PM
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
Vandana Singh
-
Oct 27, 2023, 1:00PM
Morgan Stanley Maintains Equal-Weight on PTC Therapeutics, Lowers Price Target to $28
Benzinga Newsdesk
-
Oct 27, 2023, 9:40AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Oct 27, 2023, 9:05AM
PTC Therapeutics shares are trading lower after the company reported worse-than-expected Q3 financial results.
Benzinga Newsdesk
-
Oct 27, 2023, 8:38AM
Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday
Lisa Levin
-
Oct 27, 2023, 8:06AM
Barclays Maintains Equal-Weight on PTC Therapeutics, Lowers Price Target to $25
Benzinga Newsdesk
-
Oct 27, 2023, 7:36AM
Citigroup Downgrades PTC Therapeutics to Sell, Lowers Price Target to $17
Benzinga Newsdesk
-
Oct 27, 2023, 6:43AM
Thursday, October 26, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Oct 26, 2023, 5:31PM
PTC Therapeutics Q3 2023 EPS $(1.76) Misses $(1.17) Estimate, Sales $196.58M Miss $210.19M Estimate
Benzinga Newsdesk
-
Oct 26, 2023, 4:50PM
Earnings Scheduled For October 26, 2023
Benzinga Insights
-
Oct 26, 2023, 7:20AM
Wednesday, October 25, 2023
Earnings Preview: PTC Therapeutics
Benzinga Insights
-
Oct 25, 2023, 2:02PM
Thursday, October 19, 2023
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
Lisa Levin
-
Oct 19, 2023, 2:37PM
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 19, 2023, 1:52PM
PTC Therapeutics shares are trading higher after the company announced an agreement with Royalty Pharma to monetize up to $1.5 billion of the Evrysdi Royalty Stream
Benzinga Newsdesk
-
Oct 19, 2023, 1:26PM
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Oct 19, 2023, 9:56AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Oct 19, 2023, 9:06AM
PTC Therapeutics Announced An Agreement With Royalty Pharma To Monetize Up To $1.5B Of The Evrysdi Royalty Stream. Under The Agreement, Royalty Pharma Acquires Additional Royalties On Evrysdi For $1B Upfront
Benzinga Newsdesk
-
Oct 19, 2023, 8:07AM
Friday, October 06, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
Benzinga Insights
-
Oct 6, 2023, 11:00AM
Truist Securities Downgrades PTC Therapeutics to Hold, Announces $25 Price Target
Benzinga Newsdesk
-
Oct 6, 2023, 5:10AM
Wednesday, October 04, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 4, 2023, 12:01PM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch